Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2006
Epidemiology of head and neck cancer in the United States.
СтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Davies Louise, Welch H Gilbert
Аннотация
BACKGROUND: Cancer rates of the head and neck are traditionally linked to public health issues.
OBJECTIVE: To describe the epidemiology of head and neck cancer in the United States.
DESIGN AND SETTING: National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program.
RESULTS: A total of 75,000 cases of head and neck cancer were diagnosed in 2001. Incidence is rising in thyroid (up 52%), bone (43%) soft tissues (20%), salivary (20%), tongue (16%), tonsil (12%), and nose (12%). Incidence is falling in lip (down 58%), hypopharynx (35%), cervical esophagus (32%), oropharyngeal mucosa (26%), and larynx (26%). There were 30,000 deaths from head and neck cancer in 2001. Mortality has decreased to some degree at all sites except thyroid where it was stable.
CONCLUSION: Many head and neck cancers have changing incidence and mortality rates contrary to expected changes given trends in public health issues. Further investigation of risk factors, diagnostic practices, and management strategies is warranted.
EBM RATING: 2C.
OBJECTIVE: To describe the epidemiology of head and neck cancer in the United States.
DESIGN AND SETTING: National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program.
RESULTS: A total of 75,000 cases of head and neck cancer were diagnosed in 2001. Incidence is rising in thyroid (up 52%), bone (43%) soft tissues (20%), salivary (20%), tongue (16%), tonsil (12%), and nose (12%). Incidence is falling in lip (down 58%), hypopharynx (35%), cervical esophagus (32%), oropharyngeal mucosa (26%), and larynx (26%). There were 30,000 deaths from head and neck cancer in 2001. Mortality has decreased to some degree at all sites except thyroid where it was stable.
CONCLUSION: Many head and neck cancers have changing incidence and mortality rates contrary to expected changes given trends in public health issues. Further investigation of risk factors, diagnostic practices, and management strategies is warranted.
EBM RATING: 2C.
Предметные рубрики MeSH
Bone NeoplasmsEpidemiologic StudiesEsophageal NeoplasmsHead and Neck NeoplasmsHumansHypopharyngeal NeoplasmsIncidenceLaryngeal NeoplasmsLip NeoplasmsNose NeoplasmsOropharyngeal NeoplasmsPopulation SurveillanceSEER ProgramSalivary Gland NeoplasmsSoft Tissue NeoplasmsThyroid NeoplasmsTongue NeoplasmsTonsillar NeoplasmsUnited States